Allianz Asset Management
PRTK

Allianz Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Allianz Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-73,237
Closed -$710K – 2730
2018
Q3 		$710K Buy
73,237
+5,813
+9% +$58.6K ﹤0.01% 2315
2018
Q2 		$688K Buy
67,424
+4,093
+6% +$46.3K ﹤0.01% 2321
2018
Q1 		$823K Sell
63,331
-1,217
-2% -$18.1K ﹤0.01% 2264
2017
Q4 		$1.16M Sell
64,548
-818
-1% -$17.1K ﹤0.01% 2193
2017
Q3 		$1.64M Buy
65,366
+3,719
+6% +$86.6K ﹤0.01% 2079
2017
Q2 		$1.49M Buy
61,647
+13,628
+28% +$301K ﹤0.01% 2090
2017
Q1 		$924K Buy
+48,019
New +$757K ﹤0.01% 2263

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Allianz Asset Management's PRTK Position: Q4 2018 in Review

Allianz Asset Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2018, closing a stake of 73,237 shares — an estimated $710K sold.

Allianz Asset Management first reported a position in PRTK in Q1 2017 and held it in 7 quarters. The position peaked at $1.64M in Q3 2017. 102 funds tracked by Wall St. Rank hold PRTK as of Q4 2018.

  • Allianz Asset Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Allianz Asset Management sold 73,237 Paratek Pharmaceuticals, Inc. shares in Q4 2018, an estimated $710K.
  • Allianz Asset Management first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2017 and held it in 7 quarters.
  • Allianz Asset Management's Paratek Pharmaceuticals, Inc. position peaked at $1.64M in Q3 2017.
  • 102 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2018.

Based on Allianz Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.